Want to join the conversation?
$NEE 2Q15 Q&A: Eggers from Credit Suisse asked about returns in different asset classes from NEP acquisition. Armando replied based on all of the market metrics that we looked at, a very positive acquisition both in terms of EV/EBITDA, which is around 12-12.5 times, but also in terms of cash available for distribution.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?